David J Kuter Selected Research

polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)

12/2011	What is the potential for thrombopoietic agents in acute leukemia?
12/2006	Haematological malignancies developing in previously healthy individuals who received haematopoietic growth factors: report from the Research on Adverse Drug Events and Reports (RADAR) project.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Kuter Research Topics

Disease

50	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 10/2022 - 10/2006
27	Thrombocytopenia (Thrombopenia) 10/2022 - 08/2002
21	Hemorrhage 01/2022 - 03/2009
15	Neoplasms (Cancer) 01/2022 - 01/2004
11	Thrombosis (Thrombus) 01/2021 - 01/2004
6	Liver Diseases (Liver Disease) 01/2022 - 07/2010
4	Infections 01/2022 - 01/2004
4	COVID-19 01/2022 - 01/2020
4	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2010
4	Autoimmune Hemolytic Anemia (Cold Agglutinin Disease) 01/2022 - 01/2020
4	Hepatitis C 02/2021 - 01/2011
4	Gaucher Disease (Gaucher's Disease) 01/2020 - 10/2011
3	Thromboembolism 01/2021 - 01/2009
3	Leukemia 12/2016 - 11/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 07/2013 - 07/2010
2	Hemolysis 01/2022 - 01/2021
2	Aplastic Anemia (Anemia, Hypoplastic) 01/2022 - 02/2021
2	Thrombocytosis (Thrombocythemia) 01/2021 - 07/2020
2	Hereditary Hemorrhagic Telangiectasia 01/2021 - 01/2020
2	Anemia 01/2021 - 08/2002
2	Iron Overload 01/2021 - 01/2018
2	Fatigue 01/2021 - 01/2021
2	Thrombotic Thrombocytopenic Purpura 06/2020 - 02/2009
2	Critical Illness (Critically Ill) 01/2020 - 02/2006
2	Disseminated Intravascular Coagulation 01/2020 - 11/2018
2	Febrile Neutropenia 12/2017 - 10/2013
2	Fibrosis (Cirrhosis) 05/2013 - 11/2007
2	Venous Thrombosis (Deep-Vein Thrombosis) 08/2012 - 02/2005
2	Body Weight (Weight, Body) 10/2011 - 10/2006
2	Pathologic Complete Response 09/2007 - 12/2006
1	Rheumatoid Arthritis 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Pain (Aches) 01/2022
1	Proteinuria 01/2021
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Epistaxis (Nosebleed) 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Pregnancy Complications 11/2020

Drug/Important Bio-Agent (IBA)

42	Inosine Triphosphate (ITP)IBA 10/2022 - 10/2006
25	romiplostim FDA Link 12/2021 - 02/2008
14	Thrombopoietin ReceptorsIBA 02/2021 - 02/2008
10	Thrombopoietin (c-mpl Ligand)IBA 12/2021 - 02/2008
7	eltrombopag FDA Link 12/2018 - 06/2007
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020 - 11/2002
6	Reticulin (Reticular Fiber)IBA 05/2013 - 11/2007
5	serum P-component (CIt)IBA 01/2022 - 01/2011
5	Heparin (Liquaemin)FDA LinkGeneric 11/2018 - 01/2004
5	Pharmaceutical PreparationsIBA 01/2018 - 05/2005
4	Hemoglobins (Hemoglobin)IBA 01/2022 - 07/2020
4	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021 - 03/2015
4	avatrombopagIBA 02/2021 - 06/2014
4	AntibodiesIBA 01/2020 - 05/2005
3	AutoantibodiesIBA 01/2022 - 12/2006
3	Rituximab (Mabthera)FDA Link 01/2020 - 04/2014
2	sutimlimabIBA 01/2022 - 01/2021
2	Bevacizumab (Avastin)FDA Link 01/2021 - 01/2018
2	Complement System Proteins (Complement)IBA 01/2021 - 07/2020
2	fibrin fragment D (D-dimer)IBA 12/2020 - 01/2020
2	AnticoagulantsIBA 01/2020 - 08/2017
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 11/2018
2	Immunoglobulin G (IgG)IBA 01/2020 - 05/2005
2	von Willebrand FactorIBA 06/2019 - 02/2009
2	EnzymesIBA 01/2019 - 11/2017
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2018 - 01/2004
2	Bortezomib (Velcade)FDA Link 04/2015 - 07/2009
2	miglustat (Zavesca)FDA Link 08/2013 - 10/2011
2	polyethylene glycol-recombinant human megakaryocyte growth and development factor (PEG-MGDF)IBA 12/2011 - 12/2006
2	Linezolid (Zyvox)FDA Link 12/2003 - 08/2002
1	Hemin (Panhematin)FDA Link 01/2022
1	givosiranIBA 01/2022
1	Aminolevulinic Acid (Levulan)FDA Link 01/2022
1	PorphobilinogenIBA 01/2022
1	Acute Hepatic PorphyriaIBA 01/2022
1	fostamatinibIBA 01/2022
1	Complement C1s (C1 Esterase)IBA 01/2022
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2022
1	Syk KinaseIBA 01/2022
1	Intravenous Immunoglobulins (IVIG)FDA Link 11/2021
1	Antiviral Agents (Antivirals)IBA 02/2021
1	lusutrombopagIBA 02/2021
1	BilirubinIBA 01/2021
1	IronIBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Complement Inactivating AgentsIBA 01/2021
1	insulin receptor-related receptor (IRR)IBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 01/2021
1	prothrombin fragment 1.2IBA 12/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2020

Therapy/Procedure

18	Drug Therapy (Chemotherapy) 01/2022 - 11/2002
14	Therapeutics 01/2022 - 09/2007
5	Platelet Transfusion (Blood Platelet Transfusions) 01/2022 - 11/2002
3	Splenectomy 10/2022 - 11/2010
3	Blood Component Removal (Apheresis) 07/2013 - 01/2009
3	Stem Cell Transplantation 01/2009 - 11/2002
2	Aftercare (After-Treatment) 01/2021 - 10/2009
2	Treatment Delay 01/2021 - 10/2013
2	Drug Tapering 01/2021 - 10/2013
2	Enzyme Replacement Therapy 01/2020 - 10/2011
2	Catheters 02/2005 - 01/2004